Cognitive behavioral therapy and lisdexamfetamine, alone and combined, for binge-eating disorder with obesity: a randomized controlled trial / Carlos M. Grilo en The American Journal of Psychiatry, Año 2025 - Vol. 182 - No.2 (Febrero)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2025 - Vol. 182 - No.2 (Febrero) . - pp. 209–218 Título : Cognitive behavioral therapy and lisdexamfetamine, alone and combined, for binge-eating disorder with obesity: a randomized controlled trial Tipo de documento: texto impreso Autores: Carlos M. Grilo, Autor ; Cenk Tek, Autor Fecha de publicación: 2025 Artículo en la página: pp. 209–218 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Cognitivo, Psicoterapia, Atracones, Terapia cognitivo-conductual, Trastornos alimentarios, Obesidad, Farmacoterapia, Pérdida de peso. Resumen: Binge-eating disorder (BED) is a prevalent, costly public health problem associated with serious functional impairments and heightened rates of psychiatric and medical comorbidities. Few evidence-based treatments are currently available for BED. Link: ./index.php?lvl=notice_display&id=31586 [artículo] Cognitive behavioral therapy and lisdexamfetamine, alone and combined, for binge-eating disorder with obesity: a randomized controlled trial [texto impreso] / Carlos M. Grilo, Autor ; Cenk Tek, Autor . - 2025 . - pp. 209–218. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2025 - Vol. 182 - No.2 (Febrero) . - pp. 209–218 Palabras clave: Cognitivo, Psicoterapia, Atracones, Terapia cognitivo-conductual, Trastornos alimentarios, Obesidad, Farmacoterapia, Pérdida de peso. Resumen: Binge-eating disorder (BED) is a prevalent, costly public health problem associated with serious functional impairments and heightened rates of psychiatric and medical comorbidities. Few evidence-based treatments are currently available for BED. Link: ./index.php?lvl=notice_display&id=31586

---

1 (1 - 1 / 1)